advertisement

---

Naderi Beni A 7

Showing records 1 to 7 | Display all abstracts from Naderi Beni A

96187 Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma
Pakravan M
Journal of drug assessment 2021; 10: 91-96

---

95837 Comparison of peripapillary and macular vascular density in primary open-angle glaucoma, pseudoexfoliation glaucoma, and normal control eyes
Naderi Beni A
Photodiagnosis and photodynamic therapy 2021; 37: 102611

---

96187 Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma
Naderi Beni A
Journal of drug assessment 2021; 10: 91-96

---

95837 Comparison of peripapillary and macular vascular density in primary open-angle glaucoma, pseudoexfoliation glaucoma, and normal control eyes
Imani Z
Photodiagnosis and photodynamic therapy 2021; 37: 102611

---

96187 Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma
Yazdani S
Journal of drug assessment 2021; 10: 91-96

---

95837 Comparison of peripapillary and macular vascular density in primary open-angle glaucoma, pseudoexfoliation glaucoma, and normal control eyes
Ghanbari H
Photodiagnosis and photodynamic therapy 2021; 37: 102611

---

96187 Efficacy and safety of timolol-dorzolamide fixed-combination three times a day versus two times a day in newly diagnosed open-angle glaucoma
Esfandiari H; Mirshojaee S
Journal of drug assessment 2021; 10: 91-96

---